S&P 및 Nasdaq 내재가치 문의하기

Adverum Biotechnologies, Inc. ADVM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+244%

Adverum Biotechnologies, Inc. (ADVM) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Zygtech, LLC 2,442,776 주 보유. 기타 주요 보유자에는 Salzman Amber 및 Chalberg Thomas W..

지난 12개월간 내부자는 21 건의 거래를 수행 ADVM 주식 — 12 건 매수 (평가액 $1.34M) 및 3 건 매도 (평가액 $26.02K). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

ADVM 내부자 보유 현황

최대 보유자
Zygtech, LLC
2,442,776 주
매수 (12개월)
12
$1.34M 평가액
매도 (12개월)
3
$26.02K 평가액
12개월 거래 활동
매수 57%
매도 14%
내부자 주요 보유자
# 이름 직책 보유 주식수 최종 신고일 상대적 규모
1 Zygtech, Llc 10 Percent Owner 2,442,776 2015-04-15
100%
2 Salzman Amber President and CEO 478,000 2018-02-20
20%
3 Chalberg Thomas W. Chief Executive Officer 258,988 2015-06-11
11%
4 Rakow John SVP, Genl Counsel, Acting CFO 250,000 2022-06-10
10%
5 Patterson Leone D President and CFO 240,000 2021-02-18
10%
6 Beckman Richard Chief Medical Officer 225,000 2023-03-03
9%
7 Clark Julie Chief Medical Officer 164,723 2021-10-04
7%
8 Braun Shirley VP, Human Resources 161,140 2016-02-17
7%
9 Countouriotis Athena SVP, Chief Medical Officer 160,000 2018-02-20
7%
10 Osborne Aaron Chief Medical Officer 150,000 2021-02-18
6%
11 Leonard Braden Michael 10 Percent Owner 141,800 2025-04-28
6%
12 Hull Hans Chief Executive Officer 137,210 2015-08-25
6%
13 Leung Thomas Chief Financial Officer 120,000 2020-02-21
5%
14 Thedinga Angela Chief Technology Officer 120,000 2021-08-10
5%
15 Riley Brigit Chief Scientific Officer 117,435 2023-03-17
5%
16 Fischer Laurent CEO, President and Director 87,488 2025-05-16
4%
17 Barone Samuel B. SVP, Clinical Development 84,000 2017-02-13
3%
18 Swartzburg Michael Principal Accounting Officer 82,113 2016-02-17
3%
19 Cheng Jennifer C. General Counsel 80,000 2019-02-19
3%
20 Rubio Roman G. SVP, Translational Medicine 75,000 2016-02-17
3%
최근 거래 (최근 12개월)
날짜 이름 직책 유형 주식수 주가 금액
2025-06-17 Kiss Szilard Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Hong Soo Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Seyedkazemi Setareh Chief Development Officer 주식 반환 8,500 $12.90 $109.65K
2025-06-10 Seyedkazemi Setareh Chief Development Officer 주식 반환 40,000 $19.90 $796K
2025-06-17 Ozden Rabia Gurses Chief Medical Officer 주식 반환 8,000 $13.50 $108K
2025-06-17 Lupher, Jr. Mark L. Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Soparkar Peter Chief Operating Officer 주식 반환 40,000 $68.80 $2.75M
2025-06-17 Nicholson, C. David Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Svoronos Dawn Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Tuckson Reed Vaughn Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Fischer Laurent CEO, President and Director 주식 반환 68,000 $134.40 $9.14M
2025-06-17 Scopa James Paul Director RSU 부여 10,450 $2.32 $24.24K
2025-06-17 Rubinstein Linda M Chief Financial Officer 주식 반환 35,000 $19.90 $696.5K
2025-06-17 Machado Patrick Director RSU 부여 3,140 $2.32 $7.28K
2025-06-17 Whitcup Scott M Director RSU 부여 10,450 $2.32 $24.24K
2025-05-15 Seyedkazemi Setareh Chief Development Officer 정보 매도 924 $2.00 $1.85K
2025-05-15 Soparkar Peter Chief Operating Officer 정보 매도 2,960 $2.00 $5.92K
2025-05-15 Fischer Laurent CEO, President and Director 정보 매도 9,126 $2.00 $18.25K
2025-03-27 Leonard Braden Michael 10 Percent Owner 정보 매수 16,593 $5.19 $86.09K
2025-04-23 Leonard Braden Michael 10 Percent Owner 정보 매수 50,000 $2.98 $148.95K
2025-04-22 Leonard Braden Michael 10 Percent Owner 정보 매수 300,000 $3.00 $900K
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기